4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:血浆蛋白
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > human_antigen > Haematologic Technologies/Human von Willebrand Factor - Haematologic Technologies, Inc./HCVWF-0191/HCVWF-0191-100 µg
商品详细Haematologic Technologies/Human von Willebrand Factor - Haematologic Technologies, Inc./HCVWF-0191/HCVWF-0191-100 µg
Haematologic Technologies/Human von Willebrand Factor - Haematologic Technologies, Inc./HCVWF-0191/HCVWF-0191-100 µg
Haematologic Technologies/Human von Willebrand Factor - Haematologic Technologies, Inc./HCVWF-0191/HCVWF-0191-100 µg
商品编号: HCVWF-0191-100µg
品牌: haemtech
市场价: ¥7820.00
美元价: 4692.00
产地: 美国(厂家直采)
公司:
产品分类: 人体抗原
公司分类: human_antigen
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

Von Willebrand factor (vWF) is a multimeric plasma glycoprotein that is required for normal hemostatic platelet plug formation (1-8). The mature plasma protein is composed of apparently identical subunits (Mr=260,000) which are held together by disulfide bonds. The circulating vWF molecule ranges in size from dimers (Mr=520,000) to extremely large multimers (Mr>10,000,000). During normal hemostasis, the larger multimers of vWF are responsible for facilitating platelet plug formation by forming a bridge between platelet glycoprotein IB and exposed collagen in the subendothelium (9-14). Either a lack of vWF protein or the presence of abnormalities which result in decreased polymerization may cause a loss of biological activity which is characteristic of von Willebrand"s disease.

In addition to its role in platelet plug formation, vWF is also responsible for the binding and transport of factor VIII (antihemophilic factor) in plasma (15). It appears that this latter event is responsible for both the stability and effective delivery of functional factor VIII. Studies indicate that factor VIII binds to the NH2-terminal portion of the mature vWF subunit with a stoichiometry of one factor VIII molecule per vWF monomer (16,17).

The single chain vWF monomer contains a large number of cysteine residues at both the NH2-terminal and COOH-terminal ends, which are involved in the multimer formation. Carbohydrate analyses indicate that nearly 15% of the mass of vWF is contributed by carbohydrate (18). It appears that the carbohydrate serves to protect vWF from proteolysis, but is not necessary for functional activity or multimer formation.

vWF is prepared from citrated human plasma using a combination of the procedures described by Thorell (19), and Lollar (20). A factor VIII "free" vWF preparation, further purified to ensure removal of factor VIII procoagulant activity (antigen still present), is also available. The preparations are >95% pure as judged by SDS-PAGE under reducing conditions, and consist of large multimers as determined by electrophoresis in SDS/agarose gels. The protein is shipped frozen in 0.025M sodium citrate, 0.1M glycine, 0.1M NaCl, pH 6.8, for storage at -70°C.

品牌介绍
Haematologic Technologies是一家通过ISO 9001:2015认证的公司,是一家主要制造商,专门从事旨在用于体外研究的高质量血浆蛋白的分离和表征的主要制造商。HT的重点是参与凝血级联反应的蛋白质,以及骨代谢的调节。HT产品系列包括150多种高度纯化且特性良好的蛋白质,包括酶原,酶,辅因子和抑制剂,以及单克隆和多克隆抗体的互补产品系列。还提供因子不足的血浆和定制的用于临床研究的定制采血管。提供的服务包括定制蛋白质纯化,蛋白质修饰,分析开发,合同制造和合同研究。